Christopher J. Kopka

779 total citations
10 papers, 122 citations indexed

About

Christopher J. Kopka is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Christopher J. Kopka has authored 10 papers receiving a total of 122 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 4 papers in Hepatology and 2 papers in Infectious Diseases. Recurrent topics in Christopher J. Kopka's work include Liver Disease Diagnosis and Treatment (6 papers), Liver Disease and Transplantation (4 papers) and Diet, Metabolism, and Disease (2 papers). Christopher J. Kopka is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Liver Disease and Transplantation (4 papers) and Diet, Metabolism, and Disease (2 papers). Christopher J. Kopka collaborates with scholars based in Spain, United States and United Kingdom. Christopher J. Kopka's co-authors include Jeffrey V. Lazarus, Zobair M. Younossi, Paul Brennan, Dana Ivancovsky‐Wajcman, Alina M. Allen, Carolina Batista, Nevin Cohen, Salim S. Abdool Karim, Yanis Ben Amor and Henry E. Mark and has published in prestigious journals such as Nature Medicine, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Christopher J. Kopka

10 papers receiving 114 citations

Peers

Countries citing papers authored by Christopher J. Kopka

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Kopka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Kopka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Kopka more than expected).

Fields of papers citing papers by Christopher J. Kopka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Kopka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Kopka. The network helps show where Christopher J. Kopka may publish in the future.

Co-authorship network of co-authors of Christopher J. Kopka

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Kopka. A scholar is included among the top collaborators of Christopher J. Kopka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Kopka. Christopher J. Kopka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Reviewing MAESTRO-NASH and the implications for hepatology and health systems in implementation/accessibility of Resmetirom 2025 ·University of Southern Denmark Research Portal (University of Southern Denmark) ·Paul Brennan, Christopher J. Kopka, (unknown), Claus D. Hansen, Naim Alkhouri, Jörn M. Schattenberg, Dana Ivancovsky‐Wajcman, (unknown), Maurice Stephan Michel, Jeffrey V. Lazarus	6
2	A call for doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitis 2025 ·The Lancet Regional Health - Europe ·Jeffrey V. Lazarus, Paul Brennan, Henry E. Mark, William Alazawi, Alina M. Allen, Christopher D. Byrne, Laurent Castéra, Cyrielle Caussy, Kenneth Cusi, Martin M. Grajower, Christopher J. Kopka, (unknown), Michael Roden, C Wendy Spearman, Frank Tacke, Vincent Wai‐Sun Wong, Mazen Noureddin	2
3	A call to action to address the steatotic liver disease public health threat in Barcelona 2025 ·The Lancet Regional Health - Europe ·Jeffrey V. Lazarus, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Juan M. Pericàs, Joan Benach, Christopher J. Kopka, Dana Ivancovsky‐Wajcman	3
4	Opportunities and challenges following approval of resmetirom for MASH liver disease 2024 ·Nature Medicine ·Jeffrey V. Lazarus, Dana Ivancovsky‐Wajcman, Henry E. Mark, Zobair M. Younossi, Christopher J. Kopka, Nevin Cohen, Meena B. Bansal, (unknown), Paul Brennan	32
5	Integrating social nutrition principles into the treatment of steatotic liver disease 2023 ·SHILAP Revista de lepidopterología ·Dana Ivancovsky‐Wajcman, Paul Brennan, Christopher J. Kopka, Shira Zelber‐Sagi, Zobair M. Younossi, Alina M. Allen, Karen R. Flórez, Jeffrey V. Lazarus	18
6	It is time to expand the fatty liver disease community of practice 2023 ·Hepatology ·Jeffrey V. Lazarus, Christopher J. Kopka, Zobair M. Younossi, Alina M. Allen	9
7	Physicians' Use of Digital Health Interventions in the Management of Nonalcoholic Fatty Liver Disease 2023 ·Clinics in Liver Disease ·Jeffrey V. Lazarus, Marcela Villota‐Rivas, (unknown), Álvaro Santos‐Laso, Paula Iruzubieta, M. Arias, (unknown), Simon Leigh, Christopher J. Kopka, Juan Turnés, José Luís Calleja, Javier Crespo	5
8	Implications from COVID-19 for future pandemic global health governance 2023 ·Clinical Microbiology and Infection ·Jeffrey V. Lazarus, (unknown), Christopher J. Kopka, Carolina Batista, Wafaa El‐Sadr, Rocío Sáenz, Ayman El-Mohandes	4
9	COVID-19 vaccine wastage in the midst of vaccine inequity: causes, types and practical steps 2022 ·BMJ Global Health ·Jeffrey V. Lazarus, Salim S. Abdool Karim, (unknown), (unknown), Carolina Batista, Yanis Ben Amor, Margaret Hellard, Booyuel Kim, Christopher J. Kopka, Prashant Yadav	36
10	The Sounds of Silence: The Libertarian Ethos of ERISA Preemption 2000 ·Florida law review ·(unknown), Christopher J. Kopka	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact